Related Experiment Video
Updated: Aug 19, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells
Lanxi Song1, Domenico Coppola, Sandy Livingston
1Thoracic Oncology/Experimental Therapeutics, University of South Florida College of Medicine, Tampa, Florida, USA.
Abstract:
Overexpression of anti-apoptotic Bcl-2 family members and deregulation of the pathways that regulate pro-apoptotic family members have been observed in non-small cell lung cancers (NSCLC). Previous reports have identified both Bcl-2 and Bcl-x(L) proteins as survival factors in lung cancer cells since reductions in these proteins can induce apoptosis and sensitize lung cancer cells to apoptosis induced by chemotherapy agents. Myeloid cell leukemia-1 (Mcl-1), another member of the Bcl-2 family, has been found to be a critical survival factor in hematopoietic cells, yet little data exists for a role of Mcl-1 in human lung cancers. We used NSCLC cell lines to explore how Mcl-1 levels affect lung cancer cell survival and studied tumors from patients to determine expression patterns of Mcl-1. NSCLC cells express abundant Mcl-1 protein and depletion of Mcl-1 levels by antisense Mcl-1 oligonucleotides induces apoptosis in A549 and H1299 lung cancer cells. Reduction in Mcl-1 levels can sensitize lung cancer cells to apoptosis induced by cytotoxic agents as well as by ionizing radiation. Lung cancer cells overexpressing Mcl-1 are less sensitive to apoptosis induced by chemotherapeutic agents, ZD1839 (an inhibitor of EGFR tyrosine kinase) and Bcl-2 or Bcl-x(L) antisense oligonucleotides. We find that epidermal growth factor (EGF) can enhance Mcl-1 protein levels in an ERK-dependent manner. Signal transduction agents that reduce Mcl-1 levels correlated with their individual ability to induce apoptosis in lung cancer cells. Finally, NSCLC tumors taken directly from patients have elevated levels of Mcl-1 protein compared with normal adjacent lung tissue. Therefore, agents that target Mcl-1 can induce apoptosis and sensitize cells to apoptosis induced by cytotoxic agents. Mcl-1 protein is overexpressed in a subset of human NSCLC and enhanced levels of Mcl-1 may protect lung cancer cells from death induced by a variety of pro-apoptotic stimuli.
Insights
Myeloid cell leukemia-1 (Mcl-1) is overexpressed in non-small cell lung cancer (NSCLC), promoting cancer cell survival. Targeting Mcl-1 induces apoptosis and sensitizes NSCLC cells to cancer treatments.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Anti-apoptotic Bcl-2 family members are often overexpressed in non-small cell lung cancer (NSCLC).
- Bcl-2 and Bcl-x(L) are known survival factors in lung cancer, with their reduction inducing apoptosis.
- The role of Myeloid cell leukemia-1 (Mcl-1) in human lung cancers is not well-established.
Purpose of the Study:
- To investigate the role of Mcl-1 in non-small cell lung cancer (NSCLC) cell survival.
- To examine Mcl-1 expression patterns in human NSCLC tumors.
- To determine if Mcl-1 targeting agents can induce apoptosis and sensitize lung cancer cells.
Main Methods:
- Utilized NSCLC cell lines to study the effects of Mcl-1 depletion on cell survival.
- Employed antisense Mcl-1 oligonucleotides to reduce Mcl-1 levels.
- Analyzed Mcl-1 expression in NSCLC tumors and adjacent normal lung tissue.
- Investigated the impact of epidermal growth factor (EGF) and signal transduction agents on Mcl-1 levels.
Main Results:
- NSCLC cells express abundant Mcl-1 protein.
- Depletion of Mcl-1 induces apoptosis in NSCLC cell lines (A549, H1299).
- Reduced Mcl-1 sensitizes lung cancer cells to cytotoxic agents and ionizing radiation.
- Overexpression of Mcl-1 confers resistance to apoptosis induced by various treatments.
- Epidermal growth factor (EGF) enhances Mcl-1 levels via an ERK-dependent pathway.
- NSCLC tumors exhibit elevated Mcl-1 protein compared to normal lung tissue.
Conclusions:
- Mcl-1 is a critical survival factor in a subset of human NSCLC.
- Targeting Mcl-1 can induce apoptosis and enhance sensitivity to cytotoxic therapies.
- Elevated Mcl-1 levels contribute to resistance against various pro-apoptotic stimuli in lung cancer cells.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
Cellular Injury V: Apoptosis and Autophagy
